No benefit of combination immunotherapy in treatment of advanced cancers: Study ...Middle East

News room odisha - News
No benefit of combination immunotherapy in treatment of advanced cancers: Study
New York, Sep 23 (IANS) Combination immunotherapy shows no additional benefit for most advanced cancers other than skin cancer, a new study has found. According to the study published in the journal JAMA Oncology, the combination immunotherapy treatment of nivolumab plus ipilimumab, a targeted therapy drug, was associated with no improvement in survival for advanced cancers other than melanoma (a form of skin cancer), when compared to nivolumab alone. The findings also suggested that nivolumab plus ipilimumab may be unnecessary for patients with advanced cancers other than melanoma, and that nivolumab monotherapy may provide similar clinical outcomes with reduced toxicity, according to the

Hence then, the article about no benefit of combination immunotherapy in treatment of advanced cancers study was published today ( ) and is available on News room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( No benefit of combination immunotherapy in treatment of advanced cancers: Study )

Apple Storegoogle play

Last updated :

Also on site :